Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-100

Hi Zior..sry about the name spelling..even a wordsmith gets it wrong from time to time..

Shares on issue do matter..a company with billions and billions of shares on issue typically won't be taken seriously by cornerstone institutions.

For the better part billions and billions of SOI would indicate to them that the company is poorly managed..

example is imugene last CR..dilution for existing holders and dont give me they could have brought more shares because some cannot..disclaimer i did by a nice chunk..however look at the absolute dismal price Paul got..look at the chart and pick where u as a shareholder would have preferred to raise in order to get max bang for your buck and make that war chest a mammoth one..

Massive soi also typically attracts a short term mentality..it creates a loose register one that the bell potters of this world seem to linger like a bad smell all over it..

off course if a take over were to eventuate a price would be negotiated based on what's on offer but imugene is not there..also if imugene were to licence out or partnership then the soi would affect shareholders based on timing as per how dilutive the process of issuing the billions of soi has been on that particular shareholder..

one can never say anything will not affect something..only with the benfit of hindsight can one truly say that something didn't affect..never say never before the fact so to speak..

ask yourself Zior..how is it that imugene has produced some fantastic results but yet here we see no instos coming on board other than the ones that sell as soon as they buy..

i would be happy for paul to consolidate as typically companies that are doing poorly fundamentally cause pain to shareholders regarding consolidation vs companies doing well fundamentally typically works out well for shareholders regarding consolidation

ps love reading your posts Zior

dyor..just my opinion and never advice